Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

The utility of hemoglobin based oxygen carriers (HBOC) - can animal studies help?

Ľutilité des transporteurs ďoxygène à base ďhémoglobine (HBOC) - les études animales peuvent-ellesaider?

  • 303 Accesses

  • 2 Citations

References

  1. 1

    Freitag M, Standl TG, Gottschalk A, et al. Enhanced central organ oxygenation after application of bovine cell-free hemoglobin HBOC-201. Can J Anesth 2005; 52: 904–14.

  2. 2

    Carmichael FJ. Recent developments in hemoglobin- based oxygen carriers--an update on clinical trials. Transfus Apheresis Sci 2001; 24: 17–21.

  3. 3

    Arnoldo BD, Minei JP. Potential of hemoglobin-based oxygen carriers in trauma patients. Curr Opin Crit Care 2001; 7: 431–6.

  4. 4

    Greenburg AG, Kim HW. Hemoglobin-based oxygen carriers. Crit Care 2004; 8(Suppl 2): S61–4.

  5. 5

    Wahr JA. Clinical potential of blood substitutes or oxygen therapeutics during cardiac surgery. Anesthesiol Clin North America 2003; 21: 553–68.

  6. 6

    Torres Filho IP, Spiess BD, Barbee RW, Ward KR, Oldenhof J, Pittman RN. Systemic responses to hemo- dilution after transfusion with stored blood and with a hemoglobin-based oxygen carrier. Anesth Analg 2005; 100: 912–20.

  7. 7

    Hare GM, Hum KM, Kim SY, Barr A, Baker AJ, Mazer CD. Increased cerebral tissue oxygen tension after extensive hemodilution with a hemoglobin-based oxygen carrier. Anesth Analg 2004; 99: 528–35.

  8. 8

    Lieberthal W, Fuhro R, Freedman JE, Toolan G, Loscalzo J, Valeri CR. O-raffinose cross-linking markedly reduces systemic and renal vasoconstrictor effects of unmodified human hemoglobin. J Pharmacol Exp Ther 1999; 288: 1278–87.

  9. 9

    Standl T, Freitag M, Burmeister MA, Horn EP, Wilhelm S, Am Esch JS. Hemoglobin-based oxygen carrier HBOC-201 provides higher and faster increase in oxygen tension in skeletal muscle of anemic dogs than do stored red blood cells. J Vasc Surg 2003; 37: 859–65.

  10. 10

    Fitzpatrick CM, Savage SA, Kerby JD, Clouse WD, Kashyap VS. Resuscitation with a blood substitute causes vasoconstriction without nitric oxide scavenging in a model of arterial hemorrhage. J Am Coll Surg 2004; 199: 693–701.

  11. 11

    Knudson MM, Lee S, Erickson V, Morabito D, Derugin N, Manley GT. Tissue oxygen monitoring during hemorrhagic shock and resuscitation: a comparison of lac- tated Ringer’s solution, hypertonic saline dextran, and HBOC-201. J Trauma 2003; 54: 242–52.

  12. 12

    York GB, Eggers JS, Smith DL, et al. Low-volume resuscitation with a polymerized bovine hemoglobin- based oxygen-carrying solution (HBOC-201) provides adequate tissue oxygenation for survival in a porcine model of controlled hemorrhage. J Trauma 2003; 55: 873–85.

  13. 13

    van Iterson M, Siegemund M, Burhop K, Ince C. Hemoglobin-based oxygen carrier provides heterogeneous microvascular oxygenation in heart and gut after hemorrhage in pigs. J Trauma 2003; 55: 1111–24.

  14. 14

    Pape A, Kleen M, Kemming G, Meisner F, Meier J, Habler O. Fluid resuscitation from severe hemorrhagic shock using diaspirin cross-linked hemoglobin fails to improve pancreatic and renal perfusion. Acta Anaesthesiol Scand 2004; 48: 1328–37.

  15. 15

    Lee SK, Morabito D, Hemphill JC, et al. Small-volume resuscitation with HBOC-201: effects on cardiovascular parameters and brain tissue oxygen tension in an out-of-hospital model of hemorrhage in swine. Acad Emerg Med 2002; 9: 969–76.

  16. 16

    Schubert A, Przybelski RJ, Eidt JF, et al. Diaspirincrosslinked hemoglobin reduces blood transfusion in noncardiac surgery: a multicenter, randomized, controlled, double-blinded trial. Anesth Analg 2003; 97: 323–32.

  17. 17

    Lamy ML, Daily EK, Brichant JF, et al. Randomized trial of diaspirin cross-linked hemoglobin solution as an alternative to blood transfusion after cardiac surgery. The DCLHb Cardiac Surgery Trial Collaborative Group. Anesthesiology 2000; 92: 646–56.

  18. 18

    Hill SE, Gottschalk LI, Grichnik K. Safety and preliminary efficacy of hemoglobin raffimer for patients undergoing coronary artery bypass surgery. J Cardiothorac Vasc Anesth 2002; 16: 695–702.

  19. 19

    Cheng DC, Mazer CD, Martineau R, et al. A phase II dose-response study of hemoglobin raffimer (Hemolink) in elective coronary artery bypass surgery. J Thorac Cardiovasc Surg 2004; 127: 79–86.

  20. 20

    Greenburg AG, Kim HW;Hemolink Study Group. Use of an oxygen therapeutic as an adjunct to intraoperative autologous donation to reduce transfusion requirements in patients undergoing coronary artery bypass graft surgery. J Am Coll Surg 2004; 198: 373–83.

  21. 21

    Sprung J, Kindscher JD, Wahr JA, et al. The use of bovine hemoglobin glutamer-250 (Hemopure) in surgical patients: results of a multicenter, randomized, single-blinded trial. Anesth Analg 2002; 94: 799–808.

  22. 22

    Levy JH, Goodnough LT, Greilich PE, et al. Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: results of a randomized, double-blind trial. J Thorac Cardiovasc Surg 2002; 124: 35–42.

  23. 23

    Raat NJ, Liu JF, Doyle MP, Burhop KE, Klein J, Ince C. Effects of recombinant-hemoglobin solutions rHb2.0 and rHb1.1 on blood pressure, intestinal blood flow, and gut oxygenation in a rat model of hemorrhagic shock. J Lab Clin Med 2005; 145: 21–32.

Download references

Author information

Correspondence to Richard I. Hall.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Hall, R.I. The utility of hemoglobin based oxygen carriers (HBOC) - can animal studies help?. Can J Anesth 52, 895 (2005). https://doi.org/10.1007/BF03022048

Download citation